Docgo Inc Revenue Growth Rates (DCGO), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Docgo Inc   (NASDAQ: DCGO)
 

DCGO's Revenue Growth by Quarter and Year

Docgo Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/DCGO/growth
https://api.csimarket.com/api/v1/companies/DCGO/fundamentals
https://api.csimarket.com/api/v1/companies/DCGO/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Financial API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
DCGO Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 73.43
2nd Quarter June 73.42
1st Quarter March 75.55
FY 222.40

DCGOs Annual Revenue
Docgo Inc 's Revenue in the fiscal year 2025 $ 322.20 millions
Docgo Inc 's Revenue in the fiscal year 2024 $ 616.56 millions
Docgo Inc 's Revenue in the fiscal year 2023 $ 624.29 millions
Docgo Inc 's Revenue in the fiscal year 2022 $ 440.52 millions
Docgo Inc 's Revenue in the fiscal year 2021 $ 318.72 millions




DCGO Revenue third quarter 2026 Y/Y Growth Comment
Docgo Inc reported Revenue growth of 3.7% year on year in the third quarter 2026, to $ 73.43 millions, this is lower than Docgo Inc 's recent average Revenue increase of 15.31%.

Looking into third quarter 2026 results within Medical Equipment & Supplies industry 151 other companies have achieved higher Revenue growth. While Docgo Inc ' s Revenue increase of 3.7% ranks overall at the positon no. 3282 in the third quarter 2026.


DCGO Revenue ( Y/Y Growth %) 2026
 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 3.7 %
2nd Quarter June -8.7 %
1st Quarter March -21.33 %
FY   -

Financial Statements
Docgo Inc 's third quarter 2026 Revenue $ 73.43 millions DCGO's Income Statement
Docgo Inc 's third quarter 2025 Revenue $ 70.81 millions Quarterly DCGO's Income Statement


DCGO Revenue (Quarter on Quarter Growth %)

 2026
 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 0.02 %
2nd Quarter June -2.82 %
1st Quarter March 0.81 %
FY (Year on Year)   -


Back to DCGO Growth rate Comparisons >> Back to DCGO Growth rate Comparisons >>


Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #152
Healthcare Sector #449
Overall #3282

Revenue Y/Y Growth Statistics
High Average Low
137.26 % 15.31 % -51.25 %
(Jun 30 2024)   (Sep 30 2025)
Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #152
Healthcare Sector #449
Overall #3282
Revenue Y/Y Growth Statistics
High Average Low
137.26 % 15.31 % -51.25 %
(Jun 30 2024)   (Sep 30 2025)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Docgo Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
54.49 % 4.34 % -25.33 %
(Jun 30 2023)  


DCGO's III. Quarter Q/Q Revenue Comment
Docgo Inc achieved in the III. Quarter 2026 below company average Revenue growth of 0.02% quarter on quarter, to $ 73.43 millions.

Although the III. Quarter 2026 Revenue Q/Q growth was lower than the regular , this has been yet encouraging story, as the III. Quarter surge, eclipses the -11.95% growth in the III. Quarter a year ago

Within Medical Equipment & Supplies industry 89 other companies have achieved higher Revenue quarter on quarter growth. While Docgo Inc 's Revenue growth quarter on quarter, overall rank is 2235.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #90
Healthcare Sector #284
Overall #2235
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #90
Healthcare Sector #284
Overall #2235
Revenue Q/Q Growth Statistics
High Average Low
54.49 % 4.34 % -25.33 %
(Jun 30 2023)  


DCGO's III. Quarter Q/Q Revenue Comment
Docgo Inc achieved in the III. Quarter 2026 below company average Revenue growth of 0.02% quarter on quarter, to $ 73.43 millions.

III. Quarter 2026 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the -11.95% in the III. Quarter a year ago.

Within Medical Equipment & Supplies industry 89 other companies have achieved higher Revenue quarter on quarter growth. While Docgo Inc 's Revenue growth quarter on quarter, overall rank is 2235.


Docgo Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)		 12 Months Ending (Mar 31 2026) 12 Months Ending (Dec 31 2025) 12 Months Ending (Sep 30 2025) 12 Months Ending (Jun 30 2025)
Cumulative Revenue 12 Months Ending $ 294.72
Y / Y Revenue Growth (TTM) -32.4 %
Year on Year Revenue Growth Overall Ranking # 3610
Seqeuential Revenue Change (TTM) -2.32 %
Seq. Revenue Growth (TTM) Overall Ranking # 3358


Cumulative Revenue growth Comment
Docgo Inc showed decline, but improvement compare to trailing twelve month Revenue decrease in Mar 31 2026. If the fiscal year would end in Jun 30 2026, Docgo Inc 's annual Revenue decline would be -32.4% year on year to $295 millions.

In the Healthcare sector 490 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2944 to 3610.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 155
Healthcare Sector # 491
Overall # 3610

Revenue TTM Y/Y Growth Statistics
High Average Low
84.51 %
 3.81 %
-49.35 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 155
Sector # 449
S&P 500 # 3358
Cumulative Revenue growth Comment
Docgo Inc showed decline, but improvement compare to trailing twelve month Revenue decrease in Mar 31 2026. If the fiscal year would end in Jun 30 2026, Docgo Inc 's annual Revenue drop would be -32.4% year on year to $295 millions.

In the Healthcare sector 490 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2944 to 3610.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 155
Healthcare Sector # 491
Overall # 3610

Revenue TTM Y/Y Growth Statistics
High Average Low
84.51 %
3.81 %
-49.35 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 155
Sector # 449
S&P 500 # 3358




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
DCGO's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue drop for the quarter ending Sep 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2026
Tenet Healthcare Corp6.47%$ 6.466 millions
Phibro Animal Health Corporation6.32%$ 6.320 millions
Mettler toledo International Inc 6.27%$ 6.273 millions
Agilon Health Inc 5.86%$ 5.864 millions
Johnson and Johnson5.86%$ 5.860 millions
Stoke Therapeutics Inc 5.86%$ 5.860 millions
Genedx Holdings Corp 5.64%$ 5.642 millions
Adma Biologics Inc 5.59%$ 5.595 millions
Innoviva Inc 5.55%$ 5.551 millions
Universal Health Services Inc 5.30%$ 5.297 millions
Acadia Healthcare Company Inc 5.14%$ 5.136 millions
Lumexa Imaging Holdings Inc 5.03%$ 5.032 millions
Bio techne Corp4.75%$ 4.753 millions
Merck and Co Inc 4.68%$ 4.683 millions
Davita Inc 4.62%$ 4.617 millions
Sotera Health Company4.61%$ 4.613 millions
Avantor Inc 4.59%$ 4.588 millions
Icu Medical Inc4.39%$ 4.388 millions
Illumina Inc 4.15%$ 4.151 millions
Agenus Inc4.14%$ 4.144 millions
United Therapeutics Corporation4.13%$ 4.128 millions
Option Care Health Inc 4.09%$ 4.086 millions
Henry Schein Inc 3.95%$ 3.953 millions
Grail Inc 3.71%$ 3.705 millions
Docgo Inc 3.70%$ 3.702 millions
Hca Healthcare Inc 3.59%$ 3.591 millions
Collegium Pharmaceutical Inc 3.43%$ 3.427 millions
Healthcare Services Group Inc 3.29%$ 3.288 millions
Cytek Biosciences Inc 3.26%$ 3.255 millions
Zimmer Biomet Holdings Inc 3.07%$ 3.073 millions


About Docgo Inc Revenue Growth Rates (DCGO), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Docgo Inc (CIK 1822359).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001628280-26-072270
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Docgo Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.